Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,851,262
-
Share change
-
+4,268,040
-
Total reported value
-
$1,394,741,115
-
Put/Call ratio
-
77%
-
Price per share
-
$35.00
-
Number of holders
-
153
-
Value change
-
-$69,062,329
-
Number of buys
-
82
-
Number of sells
-
112
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2015
As of 31 Dec 2015,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,851,262 shares.
The largest 10 holders included
Palo Alto Investors, LLC, PointState Capital LP, FMR LLC, VANGUARD GROUP INC, Partner Fund Management, L.P., GOLDMAN SACHS GROUP INC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, HealthCor Management, L.P., and STATE STREET CORP.
This page lists
153
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.